Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women

Cancer Genetics and Cytogenetics

Volumn 170, Issue 2, 2006, Pages 147-151

  Valladares, Adán ^a,b   Hernández, Normand García ^a,c   Gómez, Fabio Salamanca ^a   Curiel Quezada, Everardo ^c   Madrigal Bujaidar, Eduardo ^c   Vergara, Ma Dolores ^d   Martínez, Mónica Sierra ^d   Arenas Aranda, Diego J ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION;

ALIAS;

EID: 33749182371     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.06.002     Document Type: Article

References (32)

1. Sistema Único Integral de Vigilancia Epidemiológica (SUIVE)/Dirección General de Epidemiología (DGE)/Secretaría de Salud (SSA). Incidencia de casos nuevos de enfermedades por grupo de edad Estados Unidos Mexicanos. 2004. Available at http://sinais.salud.gob.mx. Accessed September 7, 2006.
2. Gupta D., Middleton L.P., Whitaker M.J., and Abrams J. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer. Am J Clin Pathol 119 (2003) 381-387
3. Ioannidis P., Mahaira L., Papadopoulou A., Teixeira M.R., Heim S., Andersen J.A., Evangelou E., Dafni U., Pandis N., and Trangas T. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas. Int J Cancer 104 (2003) 54-59
4. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., Kallioniemi O.P., and Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62 (2002) 6240-6245
5. Bekri S., Adelaide J., Merscher S., Grosgeorge J., Caroli-Bosc F., Perucca-Lostanlen D., Kelley P.M., Pebusque M.J., Theillet C., Birnbaum D., and Gaudray P. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet Cell Genet 79 (1997) 125-131
6. Forozan F., Mahlamaki E.H., Monni O., Chen Y., Veldman R., Jiang Y., Gooden G.C., Ethier S.P., Kallioniemi A., and Kallioniemi O.P. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 60 (2000) 4519-4525
7. Valladares A., Salamanca F., Madrigal-Bujaidar E., and Arenas D. Identification of chromosomal changes with comparative genomic hybridization in sporadic breast cancer in Mexican women. Cancer Genet Cytogenet 152 (2004) 163-166
8. Vorechovsky I., Luo L., Lindblom A., Negrini M., Webster A.D., Croce C.M., and Hammarstrom L. ATM mutations in cancer families. Cancer Res 56 (1996) 4130-4133
9. Jong Y.J., Li L.H., Tsou M.H., Chen Y.J., Cheng S.H., Wang-Wuu S., Tsai S.F., Chen C.M., Huang A.T., Hsu M.T., and Lin C.H. Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations. Cancer Genet Cytogenet 148 (2004) 55-65
10. Lai H., Ma F., Trapido E., Meng L., and Lai S. Spectrum of p53 tumor suppressor gene mutations and breast cancer survival. Breast Cancer Res Treat 83 (2004) 57-66
11. Albertson D.G. Profiling breast cancer by array CGH. Breast Cancer Res Treat 78 (2003) 289-298
12. Garcia N., Salamanca F., Astudillo-de la Vega H., Curiel-Quesada E., Alvarado I., Peñaloza R., and Arenas D. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. BMC Cancer 5 (2005) 93. http://www.biomedcentral.com/1471-2407/5/93 Available at: http://www.biomedcentral.com/1471-2407/5/93. Accessed September 19, 2006.
13. Cotran R.S., Kumar V., Robbins S.L., and Schoen F.J. Robbins pathologic basis of disease. 5th ed. (1994), W.B. Saunders, Philadelphia
14. Molmine. Bioinformatics software solutions. J-Express (2002). http://www.molmine.com Available from http://www.molmine.com. Accessed September 19, 2006.
15. Statsoft. TreeView & Cluster. 2000 Available from http://www.statsoft.com/textbook/stcluan.html. Accessed September 19, 2006.
16. Gross-Bellard M., Oudet P., and Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 36 (1973) 32-38
17. Lietard J., Musso O., Theret N., L'Helgoualc'h A., Campion J.P., Yamada Y., and Clement B. Sp1-mediated transactivation of LamC1 promoter and coordinated expression of laminin-gamma1 and Sp1 in human hepatocellular carcinomas. Am J Pathol 151 (1997) 1663-1672
18. Donnellan R., and Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 51 (1998) 1-7
19. Li H., Lahti J.M., Valentine M., Saito M., Reed S.I., Look A.T., and Kidd V.J. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics 32 (1996) 253-259
20. Sinkkonen L., Malinen M., Saavalainen K., Vaisanen S., and Carlberg C. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Nucleic Acids Res 33 (2005) 2440-2451
21. Hosokawa Y., and Arnold A. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22 (1998) 66-71
22. Benharroch D., and Birnbaum D. Biology of the fibroblast growth factor gene family. Isr J Med Sci 26 (1990) 212-219
23. Dickson C., Acland P., Smith R., Dixon M., Deed R., MacAllan D., Walther W., Fuller-Pace F., Kiefer P., and Peters G. Characterization of int-2: a member of the fibroblast growth factor family. J Cell Sci Suppl 13 (1990) 87-96
24. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., and Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 (1998) 339-352
25. Jost C.A., Marin M.C., and Kaelin Jr. W.G. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389 (1997) 191-194 [Erratum in: Nature 1999;399:817]
26. Bootsma D., Westerveld A., and Hoeijmakers J.H. DNA repair in human cells: from genetic complementation to isolation of genes. Cancer Surv 7 (1988) 303-315
27. Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J.J., and Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest 94 (1994) 703-708
28. Naismith J.H., and Sprang S.R. Tumor necrosis factor receptor superfamily. J Inflamm 47 (1995) 1-7
29. Owa T., Yoshino H., Yoshimatsu K., and Nagasu T. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8 (2001) 1487-1503
30. Ruutu M., Peitsaro P., Johansson B., and Syrjanen S. Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration. Int J Cancer 100 (2002) 318-326
31. Kimura T. Studies on deletion of 1p36 in oral squamous cell carcinoma. Nippon Jibiinkoka Gakkai Kaiho 101 (1998) 1430-1435
32. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., and Presky D.H. 1. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16 (1998) 495-521